GlassScriptPhysician profile
Jaime Carbonell
NPI 1932196375
$12,158.23
in general payments reported to CMS, 2019-2025
28 companies · $845 in 2025
The $845 reported for 2025 was more than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,862 · 2020: $1,552 · 2021: $2,651 · 2022: $1,438 · 2023: $929 · 2024: $881 · 2025: $845.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,655.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,655.49 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organogenesis INC. | $3,777.67 | 2019-2025 | Puraply, Apligraf, Cygnus Dual |
| Medline Industries LP | $3,722.83 | 2019-2021 | |
| Horizon Therapeutics Plc | $888.93 | 2019-2023 | Krystexxa |
| Musculoskeletal Transplant Foundation INC. | $649.44 | 2019-2021 | |
| Treace Medical Concepts, INC. | $630.44 | 2022-2025 | |
| Smith+Nephew, INC. | $453.06 | 2019-2023 | Stravix, Grafix Pl, Grafix |
| Abbvie INC. | $348.06 | 2021-2025 | Dalvance |
| Melinta Therapeutics, LLC | $287.42 | 2019-2021 | |
| Embody, INC. | $179.56 | 2021-2023 | |
| Wright Medical Technology, INC. | $153.37 | 2019-2020 | |
| Medela LLC | $144.76 | 2019 | |
| Zyla Life Sciences, INC. | $129.83 | 2019-2020 | |
| Bioventus LLC | $125.05 | 2019-2025 | Exogen Ultrasound Bone Healing System, Exogen Ultrasound Bone Healing System |
| Zimmer Biomet Holdings, INC. | $120.72 | 2019-2021 | |
| Averitas Pharma INC. | $87.76 | 2025 | Qutenza |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $69.52 | 2019-2021 | |
| Depuy Synthes Sales INC. | $59.86 | 2019-2021 | |
| Kci USA, INC. | $50.27 | 2020-2021 | |
| Kerecis Limited | $44.88 | 2019-2020 | |
| Amgen INC. | $44.77 | 2025 | Krystexxa |
| Aroa Biosurgery Incorporated | $36.92 | 2024 | |
| Sebela Pharmaceuticals INC. | $27.50 | 2021-2022 | |
| Integra Lifesciences Corporation | $24.55 | 2022 | |
| Next Science LLC | $23.27 | 2023 | Xperience, Surgx, Blastx |
| Paratek Pharmaceuticals, INC. | $22.18 | 2020 | |
| Pacira Pharmaceuticals Incorporated | $22.05 | 2019 | |
| Electronic Waveform Lab, INC. | $20.32 | 2019 | |
| Acell, INC. | $13.24 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jaime Carbonell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.